Cara Therapeutics Inc (CARA)
0.7919
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
0.7919
0.00 (0.00%)
After-Hours: 18:48
Cara Therapeutics Gross Profit (TTM): 14.79M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 14.79M |
September 30, 2023 | 13.53M |
June 30, 2023 | 17.98M |
March 31, 2023 | 35.47M |
December 31, 2022 | 34.60M |
Date | Value |
---|---|
September 30, 2022 | 34.29M |
June 30, 2022 | 46.80M |
March 31, 2022 | 23.80M |
December 31, 2021 | 23.03M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
13.53M
Minimum
Sep 2023
46.80M
Maximum
Jun 2022
27.14M
Average
23.80M
Median
Mar 2022
Gross Profit (TTM) Benchmarks
Nektar Therapeutics | 56.35M |
Stereotaxis Inc | 14.86M |
Cerus Corp | 90.38M |
Avid Bioservices Inc | 10.21M |
Rigel Pharmaceuticals Inc | 109.77M |